DEA Reschedules Hydrocodone Combination Products

Posted in Latest News on September 26, 2014.

On Friday, August 22nd, the U. S. Drug Enforcement Administration (DEA) published a Final Rule moving hydrocodone combination products (HCPs) from Schedule III to the more-restrictive Schedule II. This Final Rule imposes the regulatory controls and sanctions applicable to Schedule II substances on those who handle or propose to handle HCPs. The rule goes into effect 45 days from its publish date.

The entire rule text may be found here:  https://www.federalregister.gov/articles/2014/08/22/2014-19922/schedules-of-controlled-substances-rescheduling-of-hydrocodone-combination-products-from-schedule

Frequently Asked Questions regarding this change may be found here: Hydrocodone FAQs



More Latest News

 
June 16, 2022

The rule related to the standard of care for GLUTEAL FAT GRAFTING PROCEDURES has been amended. Click here for details. Continue reading


Third Quarter Performance Report
June 14, 2022

Released for the
2021 – 2022 Fiscal Year Continue reading